Brief: Kezar Life Sciences Reports Third Quarter 2022 Financial Results, Provides Business Update
Nov 10 (Reuters) - Kezar Life Sciences Inc KZR.O :
* KEZAR LIFE SCIENCES REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
* Q3 LOSS PER SHARE $0.25
* Q3 EARNINGS PER SHARE VIEW $-0.27 -- REFINITIV IBES DATA
Source text for Eikon: ID:nBw4CGrdMa
Further company coverage: KZR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kezar Life Sciences
See all newsNASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
U.S. STOCKS ON THE MOVE-Sysco, Crowdstrike, GM